Personalized Treatment of Glioblastoma: Current State and Future Perspective

Glioblastoma (GBM) is the most aggressive glial tumor of the central nervous system. Despite intense scientific efforts, patients diagnosed with GBM and treated with the current standard of care have a median survival of only 15 months. Patients are initially treated by a neurosurgeon with the goal...

Полное описание

Библиографические подробности

Главные авторы:	Alen Rončević, Nenad Koruga, Anamarija Soldo Koruga, Robert Rončević, Tatjana Rotim, Tihana Šimundić, Domagoj Kretić, Marija Perić, Tajana Turk, Damir Štimac
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2023-05-01
Серии:	Biomedicines
Предметы:	glioblastoma chemotherapy immunotherapy neurosurgery radiotherapy
Online-ссылка:	https://www.mdpi.com/2227-9059/11/6/1579
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!